Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

A new study suggests GLP-1 receptor agonists like Ozempic and Wegovy may significantly improve colon cancer survival rates.

Novo Nordisk NVO is a dominant player in the cardiometabolic space, marketing its blockbuster semaglutide-based (GLP-1) drugs ...

In a 71-week, double-blind study, Nova Nordisk—creators of the popular weight loss drug Wegovy—says their oral semaglutide ...

The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, known as GLP-1 medications, now cost as much as $1,350 a month. Under the ...

Generic drugmaker Sandoz expects unbranded versions of Novo Nordisk's blockbuster diabetes drug Ozempic to launch in Canada ...

Costco customers can now buy Ozempic and Wegovy at the discount chain's drugstores. Novo Nordisk, the Danish pharmaceutical firm that makes the weight-loss drugs, announced Friday that Ozempic and ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which was already widely used in a country ...

How Ozempic Is Changing Thanksgiving According to the independent research and polling source KFF, one in eight Americans reported taking a GLP-1 receptor agonist ...